MAUDE Adverse Event Report: DEPUY ORTHOPAEDICS INC US PFC SIGMARP STB TB IN 3 17.5; SIGMA KNEE PRIMARY : KNEE TIBIAL INSERT

Model Number	96-2134
Medical Device Problem Code	Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes	Pain (1994); Joint Laxity (4526)
Date of Event	12/08/2020
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
(b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
Event or Problem Description
The patient was revised to address varus/valgus instability, pain and loosening of the tibial component at the cement to implant interface.Unknown cement was used.Nothing further information.No surgical delay.Doi: unknown; dor: (b)(6) 2020; left knee.
Event or Problem Description
A.Please verify if the reported femoral component is an attune or sigma product.In the der, the reported products are attune ps femur, 2.5 attune rp and attune rp ps 17.5 poly.While upon entering the reported lot numbers in the ecm, these products were captured: mbt cem keel tib tray sz2.5 (129433125/2167789) and pfc sigmarp stb tb in 3 17.5 (962134/3063228).B.Event description states, "patient has been revised 3 times prior" and in the additional information received, it was stated that "unaware of prior complaint or der reports".Please clarify if the previous revisions involves depuy products? if yes, please provide reason for revision and product details of the explanted devices.Answer: not sure if prior surgeries were depuy products or not.Patient was sent this facility from out of the area, from what i was told.
Additional Manufacturer Narrative
Product complaint # (b)(4).Investigation summary: no device associated with this report was received for examination.A worldwide complaint database search found no other related reported incidents against the provided product code/lot number combination since release for distribution.Based on previous investigations, this complication of joint replacement is unlikely to have been the result of a device failing to meet required specifications.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Device history lot : the product investigation found no evidence suspecting an error in the manufacturing or material that would be a contributing factor in the reported allegation(s).Where the lot code was provided, a manufacturing records evaluation (mre) was not performed.H10 additional narrative: added: b5.

• Brand Name: PFC SIGMARP STB TB IN 3 17.5
• Common Device Name: SIGMA KNEE PRIMARY : KNEE TIBIAL INSERT
• Manufacturer (Section D): DEPUY ORTHOPAEDICS INC US; 700 orthopaedic drive; warsaw IN 46581 0988
• MDR Report Key: 11081375
• Report Number: 1818910-2020-27464
• Device Sequence Number: 3260712
• Product Code: NJL
• UDI-Device Identifier: 10603295241270
• UDI-Public: 10603295241270
• Combination Product (Y/N): N
• Initial Reporter State: VA
• Initial Reporter Country: US
• PMA/510(K) Number: P830055
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Explanted Year: 2020
• Serviced by Third Party (Y/N): Unknown
• Reporter Type: Manufacturer
• Report Source: company representative,health
• Initial Reporter Occupation: Other Health Care Professional
• Type of Report: Initial,Followup
• Report Date (Section B): 12/08/2020

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Operator of Device: Health Professional
• Device Model Number: 96-2134
• Device Catalogue Number: 962134
• Device Lot Number: 3063228
• Was Device Available for Evaluation?: No
• Initial Date Received by Manufacturer: 12/08/2020
• Supplement Date Received by Manufacturer: 01/18/2021
• Initial Report FDA Received Date: 12/28/2020
• Supplement Report FDA Received Date: 01/19/2021
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Patient Sequence Number: 1
• Concomitant Medical Products and Therapy/Usage Dates: MBT CEM KEEL TIB TRAY SZ2.5.; UNK ATTUNE FEMORAL.; MBT CEM KEEL TIB TRAY SZ2.5; UNK ATTUNE FEMORAL
• Outcome Attributed to Adverse Event: Required Intervention
• Patient Age: 62 YR
• Patient Weight: 85